HELP · Helus Pharma Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-30 | So Eric H. L. |
Director, Executive Chair |
Award↑
Filing footnotes — Common Shares (Direct)
Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting. Each RSU represents a right to receive one share of the Issuer's common stock. |
Common Shares
|
248,000 |
| 2026-09-30 | Glavine Paul |
Chief Growth Officer |
Award↑
Filing footnotes — Common Shares (Direct)
Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting. Each ("RSU") represents a right to receive one share of the Issuer's common stock. Includes 230,941 shares previously reported as indirect holdings by the PLG Family Trust, which have been transferred to the Reporting Person. Due to rounding, the number of shares has been reduced to 230,939. |
Common Shares
|
248,000 |
| 2026-09-29 | Cavers Greg |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Shares (Indirect)
Converted from Canadian purchase price of C$18.3157 using an exchange rate of C$1.4188 = US$1.00. |
Common Shares
(I)
|
3,000 |
| 2026-09-21 | Halstead Michael |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Shares (Direct)
The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.395 to $13.53, inclusive. The reporting person undertakes to provide to Cybin Inc., any security holder of Cybin Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Common Shares
|
100,000 |
| 2026-09-08 | So Eric H. L. |
Director, Executive Chair |
Buy↑
|
Common Shares
|
100,000 |
| 2026-09-08 | Glavine Paul |
Chief Growth Officer |
Buy↑
|
Common Shares
|
100,000 |
| 2026-09-08 | Glavine Paul |
Chief Growth Officer |
Buy↑
|
Common Shares
|
100,000 |
| 2026-09-04 | So Eric H. L. |
Director, Executive Chair |
Buy↑
|
Common Shares
|
100,000 |
| 2026-09-03 | Glavine Paul |
Chief Growth Officer |
Buy↑
|
Common Shares
|
100,000 |
| 2026-09-01 | So Eric H. L. |
Director, Executive Chair |
Buy↑
|
Common Shares
|
95,000 |
| 2026-08-31 | Glavine Paul |
Chief Growth Officer |
Buy↑
|
Common Shares
|
90,000 |